Auxly Cannabis Group Inc CBWTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CBWTF is a good fit for your portfolio.
News
-
AUXLY ANNOUNCES COMPLETION OF CONVERSION OF OVER $123 MILLION OF PRINCIPAL AND INTEREST UNDER IMPERIAL DEBENTURE
-
AUXLY REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES OUTLOOK FOR 2024
-
AUXLY TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON MARCH 25, 2024
-
AUXLY COMPLETES AMENDMENT AND EXTENSION OF AUXLY LEAMINGTON CREDIT FACILITY
-
Organigram's stock soars as British American Tobacco invests $91.3 million
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.01–0.05
- Bid/Ask
- $0.04 / $0.04
- Market Cap
- $46.23 Mil
- Volume/Avg
- 120,304 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.49
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company's focus is on developing, manufacturing, and distributing branded cannabis products. The group activities operate through two segments which include Canadian Cannabis operations, and South American Cannabis operations.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 369
- Website
- https://www.auxly.com
Valuation
|
Metric
|
CBWTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.49 |
Price/Cash Flow | — |
Price/Earnings
CBWTF
Financial Strength
|
Metric
|
CBWTF
|
|---|---|
Quick Ratio | 0.30 |
Current Ratio | 0.64 |
Interest Coverage | −0.86 |
Quick Ratio
CBWTF
Profitability
|
Metric
|
CBWTF
|
|---|---|
Return on Assets (Normalized) | −11.97% |
Return on Equity (Normalized) | −1,523.58% |
Return on Invested Capital (Normalized) | −5.16% |
Return on Assets
CBWTF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Kcnshxcnpc | Fcsdcp | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Gcmrsglhv | Mmkk | $68.9 Bil | |
HLN
| Haleon PLC ADR | Krcgxjqk | Qszhg | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xzdvjfvt | Cvwh | $14.7 Bil | |
VTRS
| Viatris Inc | Jsckljmx | Vbqh | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Twxzymhc | Ybgm | $11.9 Bil | |
CTLT
| Catalent Inc | Lcsjplsp | Lxqbg | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Swjdxtxt | Wnhkc | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ntpqdstkg | Lxsn | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Sjcrfvnq | Qzbnhy | $3.5 Bil |